205393-22-2: Bortezomib Pinanediol Impurity

Bortezomib Pinanediol Impurity (CAS No: 205393-22-2) or N-[(1S)-2-[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide is associate impurity of Bortezomib. Bortezomib is used in the treatment of myeloma and mantle cell lymphoma.

Additional information

Catalogue No.

VE007394

CAS No.

205393-22-2

Molecular Formula

C29H39BN4O4

Molecular Weight

518.46 g/mol

IUPAC Name

N-[(1S)-2-[[(1R)-1-[(3aS, 4S, 6S, 7aR)-Hexahydro-3a, 5, 5-trimethyl-4, 6-methano-1, 3, 2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide

References

“Sci-Hub, Development of Peptidomimetic Boronates as Proteasome Inhibitors, 10.1016/J.ejmech.2013.03.032.” Hkvisa.net, 2013, sci-hub.hkvisa.net/10.1016/j.ejmech.2013.03.032.

Status

In-stock